Vanguard Personalized Indexing Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.9K | Buy |
|
|||||
|
2025
Q1 | $34K | Buy |
|
|||||
|
2024
Q4 | $24.4K | Buy |
|
|||||
|
2024
Q3 | $48.8K | Sell |
|
|||||
|
2024
Q2 | $48.5K | Buy |
|
|||||
|
2024
Q1 | $99.7K | Buy |
|
|||||
|
2023
Q4 | $46.2K | Sell |
|
|||||
|
2023
Q3 | $30.4K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $250K | Sell |
|
|||||
|
2022
Q1 | $405K | Buy |
|
|||||
|
2021
Q4 | $236K | Buy |
|
|||||
|
2021
Q3 | $226K | Buy |
|
|||||
|
2021
Q2 | $215K | Buy |
|